electroCore (ECOR) Competitors

$5.76
+0.11 (+1.95%)
(As of 04/26/2024 ET)

ECOR vs. POCI, MOVE, RMTI, QTI, NRXS, BSGM, IRIX, HYPR, VANI, and FONR

Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include Precision Optics (POCI), Movano (MOVE), Rockwell Medical (RMTI), QT Imaging (QTI), NeurAxis (NRXS), BioSig Technologies (BSGM), IRIDEX (IRIX), Hyperfine (HYPR), Vivani Medical (VANI), and FONAR (FONR). These companies are all part of the "medical" sector.

electroCore vs.

Precision Optics (NASDAQ:POCI) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, media sentiment, earnings, analyst recommendations and profitability.

electroCore has a consensus target price of $10.00, indicating a potential upside of 77.94%. Given Precision Optics' higher possible upside, analysts clearly believe electroCore is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
electroCore
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Precision Optics had 3 more articles in the media than electroCore. MarketBeat recorded 4 mentions for Precision Optics and 1 mentions for electroCore. Precision Optics' average media sentiment score of 1.00 beat electroCore's score of 0.46 indicating that electroCore is being referred to more favorably in the news media.

Company Overall Sentiment
Precision Optics Neutral
electroCore Positive

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 16.3% of Precision Optics shares are held by company insiders. Comparatively, 13.1% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

electroCore received 164 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 62.12% of users gave electroCore an outperform vote while only 0.00% of users gave Precision Optics an outperform vote.

CompanyUnderperformOutperform
Precision OpticsOutperform Votes
No Votes
Underperform Votes
2
100.00%
electroCoreOutperform Votes
164
62.12%
Underperform Votes
100
37.88%

Precision Optics has higher revenue and earnings than electroCore. Precision Optics is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$21.05M1.61-$140K-$0.30-18.60
electroCore$16.03M2.10-$18.83M-$3.56-1.58

Precision Optics has a beta of 0.12, indicating that its stock price is 88% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.

Precision Optics has a net margin of -8.93% compared to Precision Optics' net margin of -117.49%. electroCore's return on equity of -21.74% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-8.93% -21.74% -13.02%
electroCore -117.49%-201.47%-109.61%

Summary

electroCore beats Precision Optics on 9 of the 17 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ECOR vs. The Competition

MetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$33.72M$2.71B$4.84B$7.63B
Dividend YieldN/A1.91%2.96%3.93%
P/E Ratio-1.587.64176.7816.45
Price / Sales2.1066.942,287.8481.82
Price / CashN/A58.1546.2835.09
Price / Book4.533.604.764.39
Net Income-$18.83M$76.63M$103.00M$213.88M
7 Day Performance-0.53%-0.43%0.67%1.82%
1 Month Performance-8.77%1.46%-6.26%-3.77%
1 Year Performance-15.99%2.81%9.77%9.28%

electroCore Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0 of 5 stars
$5.49
+0.5%
N/A-11.1%$33.32M$21.05M-18.3084Short Interest ↓
News Coverage
Positive News
MOVE
Movano
0 of 5 stars
$0.48
-4.0%
N/A-52.8%$26.25MN/A-0.7334Short Interest ↑
RMTI
Rockwell Medical
3.72 of 5 stars
$1.49
-2.0%
$7.00
+369.8%
-31.1%$43.70M$83.61M-3.72237
QTI
QT Imaging
0 of 5 stars
$0.85
-21.3%
N/AN/A$18.22MN/A0.00N/AGap Up
NRXS
NeurAxis
0 of 5 stars
$3.13
-1.3%
N/AN/A$16.54M$2.68M0.0017Gap Down
BSGM
BioSig Technologies
0 of 5 stars
$1.51
+37.3%
N/A-89.9%$13.56M$290,000.00-0.3147Short Interest ↑
High Trading Volume
IRIX
IRIDEX
0.0032 of 5 stars
$3.27
+3.2%
$2.00
-38.8%
+31.0%$53.14M$51.87M-5.54111Analyst Report
News Coverage
Gap Up
HYPR
Hyperfine
1.9341 of 5 stars
$0.99
-1.0%
$2.12
+113.8%
-41.5%$71.23M$11.03M-1.60131News Coverage
VANI
Vivani Medical
1.2607 of 5 stars
$1.92
-5.0%
N/A+71.2%$105.56MN/A-3.8444Short Interest ↓
Positive News
FONR
FONAR
0 of 5 stars
$16.79
-0.2%
N/A+8.6%$106.28M$98.64M9.13561

Related Companies and Tools

This page (NASDAQ:ECOR) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners